SK pharmteco Capacity Update October 2024: Cell & Gene Therapy

In this presentation, we will highlight SK pharmteco’s expanded capacity in supporting cell and gene therapy projects through our comprehensive viral vector, plasmid Development, and GMP manufacturing capabilities. Our Vectorology Services encompass every stage of development, from comprehensive plasmid design and annotation to ensuring ITR/LTR sequence integrity, along with expert management of promoters, polyA, and other critical regulatory sequences. Additionally, our cutting-edge analytical capabilities ensure thorough characterization and quality control, providing end-to-end support for your projects.

Whether you are developing early-stage gene therapies or scaling to commercial production, SK pharmteco is positioned to deliver on your needs with unparalleled expertise, capacity, and regulatory support.